ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.
作者信息
Krucoff Mitchell W, Cao Davide, Mehran Roxana
机构信息
Duke University Medical Center-Duke Clinical Research Institute, Durham, NC, USA.
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
EuroIntervention. 2022 Aug 19;18(6):448-449. doi: 10.4244/EIJ-E-22-00024.
Abstract
摘要
相似文献
1
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.ARC-HBR标准与经导管主动脉瓣置换术：并非所有高出血风险患者都一样。
EuroIntervention. 2022 Aug 19;18(6):448-449. doi: 10.4244/EIJ-E-22-00024.
2
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2.根据 ARC-HBR 标准，TAVR 后的出血风险差异：来自 SCOPE 2 的见解。
EuroIntervention. 2022 Aug 19;18(6):503-513. doi: 10.4244/EIJ-D-21-01048.
3
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.学术研究联盟高出血风险标准在经皮冠状动脉介入治疗所有患者登记中的应用。
Circ Cardiovasc Interv. 2019 Nov;12(11):e008307. doi: 10.1161/CIRCINTERVENTIONS.119.008307. Epub 2019 Nov 11.
4
Antiplatelet Treatment for Catheter-Based Interventions in High-Risk Patients: Current Guidelines and Expert Opinion.高危患者经导管介入治疗的抗血小板治疗：当前指南和专家意见。
Hamostaseologie. 2018 Nov;38(4):229-235. doi: 10.1055/s-0038-1668165. Epub 2018 Aug 8.
5
Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.基于全血栓形成分析系统的经皮冠状动脉介入治疗患者出血风险模型的建立与评估。
Int J Cardiol. 2021 Feb 15;325:121-126. doi: 10.1016/j.ijcard.2020.10.015. Epub 2020 Oct 11.
6
Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.急性冠状动脉综合征行经皮冠状动脉介入治疗中高出血风险的学术研究协作适用性。
Rev Esp Cardiol (Engl Ed). 2022 May;75(5):375-383. doi: 10.1016/j.rec.2021.03.006. Epub 2021 Apr 14.
7
Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.急性冠状动脉综合征患者的学术研究联盟高出血风险（ARC-HBR）标准数量与临床结局的关系。
J Cardiol. 2023 Jun;81(6):553-563. doi: 10.1016/j.jjcc.2023.01.003. Epub 2023 Jan 20.
8
Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).经股动脉导管主动脉瓣植入术（TAVR）治疗心房颤动与窦性心律患者的心血管死亡率、出血、血管和脑血管事件分析。
BMC Cardiovasc Disord. 2017 Dec 20;17(1):298. doi: 10.1186/s12872-017-0736-6.
9
Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.在东亚行经皮冠状动脉介入治疗的患者中高出血风险的意义和特征：从正确的而非可接受的开始。
J Cardiol. 2021 Aug;78(2):91-98. doi: 10.1016/j.jjcc.2020.12.004. Epub 2020 Dec 23.
10
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.经皮冠状动脉介入治疗后出血风险、双联抗血小板治疗停药和不良事件：PARIS 注册研究。
Circ Cardiovasc Interv. 2020 Apr;13(4):e008226. doi: 10.1161/CIRCINTERVENTIONS.119.008226. Epub 2020 Mar 27.
本文引用的文献
1
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2.根据 ARC-HBR 标准，TAVR 后的出血风险差异：来自 SCOPE 2 的见解。
EuroIntervention. 2022 Aug 19;18(6):503-513. doi: 10.4244/EIJ-D-21-01048.
2
Bleeding avoidance strategies in percutaneous coronary intervention.经皮冠状动脉介入治疗中的出血预防策略。
Nat Rev Cardiol. 2022 Feb;19(2):117-132. doi: 10.1038/s41569-021-00598-1. Epub 2021 Aug 23.
3
Assessment of the Academic Research Consortium for High Bleeding Risk Criteria in Patients Undergoing TAVR.经导管主动脉瓣置换术（TAVR）高出血风险患者学术研究联盟标准的评估。
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1265-1267. doi: 10.1016/j.jcin.2021.01.007.
4
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR.经导管主动脉瓣置换术后出血风险患者实用模型的建立与验证。
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1196-1206. doi: 10.1016/j.jcin.2021.03.024.
5
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis.冠心病患者出血与心肌梗死的死亡率：系统评价和荟萃分析。
EuroIntervention. 2021 Sep 20;17(7):550-560. doi: 10.4244/EIJ-D-20-01197.
6
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk.学术研究联盟针对高出血风险所提出的高出血风险标准及定义的验证
Eur Heart J. 2020 Oct 7;41(38):3743-3749. doi: 10.1093/eurheartj/ehaa671.
7
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.当代经皮冠状动脉介入治疗患者中学术研究联盟高出血风险定义的验证。
J Am Coll Cardiol. 2020 Jun 2;75(21):2711-2722. doi: 10.1016/j.jacc.2020.03.070.
8
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.定义经皮冠状动脉介入治疗患者的高出血风险：来自高出血风险学术研究联合会的共识文件。
Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.
9
Floor and ceiling effects in the OHS: an analysis of the NHS PROMs data set.职业健康状况调查中的地板效应和天花板效应：对英国国家医疗服务体系患者报告结局测量数据集的分析
BMJ Open. 2015 Jul 27;5(7):e007765. doi: 10.1136/bmjopen-2015-007765.
Zotero 插件